2012 Consensus Document of the Italian Society of Hypertension (SIIA): Strategies to Improve Blood Pressure Control in Italy
- 28 March 2013
- journal article
- practice guideline
- Published by Springer Nature in High Blood Pressure & Cardiovascular Prevention
- Vol. 20 (1) , 45-52
Abstract
Observational clinical studies have demonstrated that only 30–40 % of patients with arterial hypertension achieve the recommended blood pressure goals (below 140/90 mmHg). In contrast, interventional trials consistently showed that it is possible to achieve effective blood pressure targets in about 70 % of treated hypertensive patients with different cardiovascular risk profiles, especially through the use of rational, effective and well tolerated combination therapies. In order to bridge the gap between current and desired blood pressure control and to achieve more effective prevention of cardiovascular diseases, the Italian Society of Hypertension (SIIA) has developed an interventional strategy aimed at reaching nearly 70 % of treated controlled hypertensive patients by 2015. This ambitious goal can be realistically achieved by a more rational use of modern tools and supports, and also through the use of combination therapy in hypertension in daily clinical practice, especially if this approach can be simplified into a single pill (fixed combination therapy), which is a therapeutic option now also available in Italy. Since about 70–80 % of treated hypertensive patients require a combination therapy based on at least two classes of drugs in order to achieve the recommended blood pressure goals, it is of key importance to implement this strategy in routine clinical practice. Amongst the various combination therapies currently available for hypertension treatment and control, the use of those strategies based on drugs that antagonize the renin-angiotensin system, such as angiotensin II type 1 receptor antagonists (angiotensin receptor blockers) and ACE inhibitors, in combination with diuretics and/or calcium channel blockers, has been shown to significantly reduce the risk of major cardiovascular events and to improve patient compliance to treatment, resulting in a greater antihypertensive efficacy and better tolerability compared with monotherapy. The present document of the Italian Society of Arterial Hypertension (SIIA) aims to gather the main indications for the implementation of combination therapy in the treatment of hypertension, in order to improve blood pressure control in Italy.Keywords
This publication has 35 references indexed in Scilit:
- Blood pressure control in ItalyJournal Of Hypertension, 2012
- Addition of Spironolactone in Patients With Resistant Arterial Hypertension (ASPIRANT)Hypertension, 2011
- Effectiveness of nebivolol and hydrochlorothiazide association on blood pressure, glucose, and lipid metabolism in hypertensive patientsAdvances in Therapy, 2010
- Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study designNephrology Dialysis Transplantation, 2009
- Blood pressure control in Italy: results of recent surveys on hypertensionJournal Of Hypertension, 2007
- Blood pressure-dependent and independent effects of agents that inhibit the renin–angiotensin systemJournal Of Hypertension, 2007
- THE EFFECTS OF BISOPROLOLA SELECTIVE β1-BLOCKERON GLUCOSE METABOLISM BY LONG-TERM ADMINISTRATION IN ESSENTIAL HYPERTENSIONClinical and Experimental Hypertension, 2001
- Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertensionJournal Of Hypertension, 1998
- Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertensionThe Lancet, 1997
- Influence of Carvedilol on Blood Glucose and Glycohaemoglobin A1 in Non-Insulin-Dependent DiabeticsDrugs, 1988